side effects include:
patients with breast cancer
endometrial cancer
weight gain
nausea
vomiting
hypertension
vaginal bleeding
discharge
including breakthrough bleeding
hyperglycemia
asthenia
rash
patients with cachexia
diarrhea
flatulence
nausea
vomiting
hypertension
impotence
libido
asthenia
rash
insomnia
anemia
fever
hyperglycemia
pain

endocrine side effects
cases of new onset diabetes mellitus
exacerbation
preexisting diabetes mellitus
overt cushings syndrome
association of chronic use of megestrol
active ingredient
megace es
adrenal insufficiency
patients
being
chronic megestrol therapy
non-stressed state
adrenocorticotropin
acth
stimulation testing
frequent occurrence of asymptomatic pituitary-adrenal suppression in patients
chronic megestrol therapy
hot flashes
possibility of adrenal insufficiency
patient
being
chronic megestrol
signs
symptoms
hypoadrenalism
non-stressed state
general
side effects
significant risk of weight gain
increased appetite
mood changes
malaise
asthenia
lethargy
cardiovascular
side effects
thrombophlebitis
heart failure
edema
deep vein thrombosis
hypertension
blood clots
risk in cancer patients
others
clotting
hematologic side effects
significant risk
blood clots
gastrointestinal side effects
nausea
vomiting
genitourinary side effects
breakthrough
menstrual bleeding
respiratory side effects
pulmonary embolism
dyspnea
dermatologic side effects
alopecia
sweating
rash
musculoskeletal side effects
patients with severe osteoporosis
multiple vertebral fractures
patients
receiving
receiving high-dose megestrol
active ingredient
megace es
therapy
nervous system
side effects
carpal tunnel syndrome
oncologic side effects
tumor flare
hypercalcemia
long term animal studies
increased risk for both benign
malignant tumors of the breast
other side effects
possible case of megestrol
active ingredient
megace es
withdrawal syndrome